Mn Services Vermogensbeheer B.V. Nektar Therapeutics Transaction History

Mn Services Vermogensbeheer B.V.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$16.91 - $36.27 $495,463 - $1.06 Million	-29,300 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$30.43 - $56.65 $54,774 - $101,970	1,800 Added 6.55%	29,300 $842,000
Q3 2018 Nov 02, 2018	BUY	$46.46 - $68.49 $97,566 - $143,829	2,100 Added 8.27%	27,500 $1.68 Million
Q2 2018 Aug 13, 2018	BUY	$46.25 - $104.45 $1.17 Million - $2.65 Million	25,400 New	25,400 $1.24 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.